Received: 20100618; Accepted: 20101104 Grants: National Natural Science Foundation of China (No. 30670795); Natural Science Foundation of Guangdong Province (No. 10151063201000059); Guangzhou Project of Science and Technology (No. 2008Z1E271) DJ1, was firstly reported as a mitogendependent oncogene, was identified by Nagakubo . in 1997 [1] . Many studies have found that DJ1 participates in cellular biological processes of various tumors, such as proliferation and differentiation, arrest of cell cycle [2] , and autophagy [3] . In addition, DJ1 also has functions of antioxidation and molecular chaperones [4] . DJ1 gene is expressed widely in multiple human tissues. In normal human brain, DJ1 is expressed mainly in glial cells in the cerebral cortex and in neurons in the substantia nigra and corpus striatum [5] . Previous researches focused mostly on DJ1 mutations and abnormal expression regulation that lead to degeneration of the nervous system. Recent studies showed that DJ1 was closely related with tumorigenesis, progression, metastasis, and prognosis. DJ1 is highly expressed in multiple tumor tissues. In 2005, Kim . [6] found that in breast cancer cells, DJ1 negatively regulated PTEN expression, promoted phosphorylation of PI3K/Akt, and activated cell proliferation and transformation. It has been confirmed that PTEN, the first tumor suppressor gene with phosphatase activity, plays important roles in tumor invasion and metastasis. In vivo, PTEN interacts directly with FAK and induces FAK dephosphorylation, which effectively inhibits integrinmediated cell adhesion and migration [7] . In 2008, Yuan .
[8] reported high nuclear DJ1 expression in highly metastatic esophageal squamous cells; in 2009, Wu . [9] found that DJ1 was involved in metastasis of liver cancer. Therefore, DJ1 can be used as a marker of cancer metastasis and can be a potential therapeutic target.
However, the detailed mechanism is not fully understood. Glioma is the most common malignancy in the central nervous system. As mostly taking an invasive growth pattern, glioma is treated with surgical resection, radiotherapy, chemotherapy, and gene therapy, but the treatment efficacy is unsatisfactory [10] . Therefore, determining the pathogenesis of glioma and finding key factors involved in tumor migration and invasion are essential for clinical treatment. PTEN is a key regulator for glioma development. However, its upstream regulators have not been delineated. DJ1 suppresses PTEN expression, which is important for inhibiting tumorigenesis and metastasis. Whether DJ1 regulates glioma metastasis through inhibiting the PTEN/FAK pathway is unclear. In this study, we aimed to determine the mechanism of DJ1 in promoting glioma metastasis. Recombinant plasmid pEGFP/DJ1 was transfected into human glioma cell line SWO38 to induce DJ1 overexpression. DJ1 expression in SWO38 cells was knocked down by small interfering RNA (siRNA) targeting DJ1. In vitro migration and invasion was measured to test whether DJ1 was involved in this process through the PTEN/FAK pathway.
Human glioma cell line SWO38 was established in our department in 1985 [11] . SWO38 cells were cultured in RPMI1640 medium containing 10% fetal bovine serum (Hyclone ) and incubated in a 37 益 , 5 % CO 2 humidified incubator.
Antibodies to DJ1 and PTEN were purchased from Cell Signaling Technology, Inc. Antibodies to FAK and phosphoFAK were purchased from Santa Cruz Biotechnology, Inc. Lipofectamine 2000 TM was purchased from Invitrogen Inc. Transwell chamber was purchased from BD Inc.
Eukaryotic expression vector pEGFP/DJ1 was constructed in our lab. The open reading frame (ORF) of human DJ1 was amplified by reverse transcription polymerase chain reaction (RTPCR) from HeLa cells.
The sequence of forward primer was 5'GGCGAATT CATGGCTTCCAAAAGAGCT3' and that of reverse primer was 5'GCGGGTACCGTCTTTAAGAACAAGTGGA3'. R I restriction sites was introduced at the 5' end and I at the 3' end. DJ1 cDNA was cloned into the vector pEGFPC2 to prepare recombinant plasmid pEGFP/DJ1, which was confirmed by restriction enzyme digestion and DNA sequencing. siRNAs targeting human DJ1 were designed and synthesized by Shanghai GenePharma Co., Ltd. The sequence of sense strand was 5'GCUCUGUUGGCUCAU GAAATT3'; and antisense strand was 5'UUUCAUGAGCC AACAGAGCAG3'. Negative control siRNAs were non specific random sequences gifted by Shanghai GenePharma Co., Ltd. The sequence of sense strand was 5'UUCUCCGAACGUGUCACGUTT3' and antisense strand was 5'ACGUGACACGUUCGGAGAATT3'.
Fresh medium was replaced 24 h before transfection. Transfection was conducted according to the manufacturer爷s instructions. Briefly, pEGFP/DJ1 was diluted with culture medium without fetal calf serum and mixed with Lipofectamine 2000 TM for 5 min, then incubated at room temperature for 20 min and dropped into cells. Cells were collected 24 h later, and DJ1 expression was detected by Western blot. The cells without transfection or transfected with empty plasmid pEGFPC2 were used as controls.
Using the same methods in the aforementioned subsection, DJ1 siRNA was diluted to 20 nmol/L, mixed with Lipofectamine 2000 TM , and transfected into SWO38 cells. Cells were collected 24 h later, and DJ1 expression was detected by Western blot. The cells transfected with 20 nmol/L scrambled siRNA were used as controls.
The day before transfection, SWO38 cells were seeded into 6well plates to obtain 60% to 70% confluence. (1:500), rabbit antihuman GAPDH antibody (1:1000) were added into primary antibody solution (Beyotime Institute of Biotechnology). The membrane was incubated at 4益 overnight. After washed with TTBS three times, the membrane was incubated with secondary antibody solution (1:4000) at room temperature for 1 h. After three times of TTBS wash, the membrane was incubated with Super Signal west PicoChemiluminescent Substrate (Thermo) and then exposed with Xray film (FUJI).
Cells at logarithmic growth phase were cultured in serumfree RPMI1640 medium for 24 h. For invasion assay, transwell chambers were treated with 20 滋 L culture medium containing 6.7% Matrigel TM so that the inner surface of the filter membrane (diameter, 6.5 mm; pore diameter, 4 mm) was coated with extracellular matrix. Cells were treated with 2.5% trypsin and suspended in serumfree RPMI1640 medium at a concentration of 1 伊 10 6 /L. Cell suspension (200 滋 L) was added into each upper chamber and 600 滋 L RPMI1640 medium containing 10% FBS was added into each lower chamber. Then the transwell chambers were incubated in a 37益, 5% CO 2 , humidified incubator for 24 h. For cell migration assay, 100 滋 L cell suspension (2 伊 10 5 /L) was added directly into the transwell chamber (not coated with extracellular matrix) and incubated for 16 h. The cells on the inner surface of the filter membrane were removed. The cells on the lower surface of the membrane were stained with crystal violet, and counted in five random fields under 200fold light microscope.
All data are expressed as mean ± standard deviation. Analysis of variance was conducted by SPSS13.0 software package. The difference was considered statistically significant when < 0.05. RTPCR products were resolved on 1% agarose gel. A single 600 bp band was observed ( Figure 1A) , which corresponded to human DJ1 cDNA.
The validity of pEGFP/DJ1 was confirmed by R I/ I restriction enzyme digestion. A 600 bp band was observed ( Figure 1B) , which was consistent with the RTPCR result. The reading frame was confirmed by DNA sequencing.
SWO38 cells was transfected with pEGFP/DJ1 for 24 h. Compared with those in the cells transfected with empty plasmid pEGFPC2, DJ1 expression was upregulated in SWO38 cells transfected with pEGFP/DJ1 ( < 0.05); PTEN expression was downregulated ( < 0.05), and phosphoFAK was upregulated ( < 0.05) (Figure 2 ). After DJ1 siRNA transfection, DJ1 expression was suppressed, the migration and invasion of SWO38 cells were inhibited. The mean numbers of migrated cells and invaded cells were significantly lower in DJ1 siRNA group than in scrambled siRNA group ( = 12.459, < 0.05; = 23.516, < 0.05) ( Figure 5 ).
Glioma cells are characterized by migration and invasion, and can invade from primary lesion to normal brain tissue. Because of the invasive growth pattern, glioma is resistant to treatment and hard to be resected completed [10] . With the development of molecular biology, gene therapy has attracted much attention. Identifying appropriate targets is essential for successful gene therapy of glioma. The most common therapeutic target of multiforme glioblastoma is PTEN, which localizes in human chromosome 10 and shows abnormal expression. Recently, many studies confirmed that PTEN can inhibit the invasion of glioma cells [1214] . Tamura . [7] found that the inhibition of migration and invasion of glioma by PTEN was significantly correlated with the decreased phosphorylation of FAK and p130Crk substrates, that is, PTEN can promote FAK dephosphorylation and then inhibit the migration and invasion of glioma. DJ1 was initially defined as an oncogene candidate. DJ1 is expressed highly in several tumors, and can also be detected in the serum of some patients. DJ1 gene localizes on human chromosome 1p36 and spans 24 kb comprising of 8 exons, of which exon 1A and 1B are noncoding. DJ1 protein is coded by exons 27, contains 189 amino acids, and weights about 20 kD. DJ1 protein is highly conserved and belongs to the ThiJ/PfpI protein superfamily [15] . In 2009, researchers found that DJ1 reduced the phosphatase activity of PTEN and interfered with cell cycle and inhibited apoptosis by inhibiting the PTEN/Akt pathway [16] . We hypothesized that DJ1 downregulates the expression of Our results showed that overexpressing DJ1 protein in glioma cells inhibited PTEN expression and indirectly enhanced the phosphoFAK level by reducing FAK dephosphorylation. On the other hand, we knocked down DJ1 by siRNA and found that DJ1 knockdown promoted PTEN expression and indirectly lowered phosphoFAK level by increasing FAK dephosphorylation. We also found migration and invasion of glioma cells corresponded to DJ1 expression: more pEGFP/DJ1transfected SWO38 cells migrated through filter membrane than nontransfected cells; fewer DJ1knockdown SWO38 cells penetrated through filter membrane than control cells. Thus our results proved that DJ1 negatively regulated PTEN expression and further promoted migration and invasion of glioma cells by 
